SCHEMBL1997982

SCHEMBL1997982

Cc1[nH]ncc1C(c1ccc(-c2ccc(F)cc2)cc1)N1CCN(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.43
HRH3 Q9Y5N1 3/20 0.41
SLC1A2 P43004 1/20 0.40
P4HB P07237 4/20 0.40
CHRM2 P08172 2/20 0.39
ADRA2A P08913 2/20 0.39
CHRM1 P11229 2/20 0.39
DRD1 P21728 2/20 0.39
DRD3 P35462 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KCNH2 Q12809 2/20 0.39
CYP2D6 P10635 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CHRM3 P20309 1/20 0.39
ADRA1D P25100 1/20 0.39
HRH1 P35367 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998316 0.88 HRH3 (0.45) ACHEHRH3P4HBCHRM2ADRA2A
SCHEMBL5228222 0.82 HRH3 (0.39) ACHEHRH3SLC1A2P4HBCHRM2
SCHEMBL5224159 0.81 GPR55 (0.43) ACHEHRH3DRD3CYP2D6TSHR
SCHEMBL2001557 0.81 KCNH2 (0.37) HRH3P4HBKCNH2
SCHEMBL2761010 0.80 MAPT (0.41) ACHEHRH3SLC1A2P4HBCHRM2
SCHEMBL5230180 0.79 HTR1A (0.42) ACHEHRH3SLC1A2CHRM2ADRA2A
SCHEMBL2001196 0.78 ACHE (0.43) ACHEHRH3SLC1A2P4HBCHRM2
Hydrochloric Acid SCHEMBL3328376 0.78 MAPT (0.39) ACHEP4HBHTR2BPOLBHTR1A
Hydrochloric Acid SCHEMBL3324402 0.78 ACHE (0.39) ACHEP4HBHTR1AMAPT
SCHEMBL1994268 0.78 ACHE (0.45) ACHEHRH3SLC1A2CHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960413-B2 Pyrazole compounds MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A ACHE 1185/4885HRH3 111/4885SLC1A2 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.